Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights

Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate, Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting

Journey Medical Corporation to Release Year End 2021 Financial Results and Provide Corporate Update on March 23, 2022